Jt Comm J Qual Patient Saf. 2024 Nov;50(11):801-808. doi: 10.1016/j.jcjq.2024.07.009. Epub 2024 Jul 31.
Inpatient serum phosphate replacement is common, but there is great variability in replacement practice, which leads to overuse. Electronic health record (EHR) interventions with clinical decision support (CDS) can be effective tools to guide clinicians toward best clinical practices. The authors' objective was to use CDS tools to reduce overuse of hypophosphatemia corrections at a large safety-net health care system.
The first intervention involved enhancing an existing order set for phosphate repletion by incorporating CDS to guide appropriate repletion orders based on deficit severity and simplifying ordering. The second intervention was a Best Practice Advisory (BPA) that triggered when an intravenous (IV) phosphate repletion was ordered for a patient with mild to moderate phosphate deficiency without an existing nil per os (NPO) order. The primary outcome measure was the number of patients with mild and moderate hypophosphatemia receiving IV replacement without NPO orders per 1,000 patient-days.
Across all hospitals, rate of IV replacement in patients with mild to moderate hypophosphatemia (1.0 to 1.9 mg/dL) without NPO orders decreased from 7.22 to 3.40 per 1,000 patient-days (53.0% reduction, p < 0.001), while the oral replacements in this population increased from 6.39 to 8.87 (38.8% increase, p < 0.001). For patients with phosphate levels ≥ 2.0, IV replacements decreased from 10.66 to 5.36 (49.8% reduction, p < 0.001), and oral replacements from decreased 19.78 to 16.69 (15.6% reduction, p < 0.01).
This intervention successfully reduced inpatient IV phosphate replacements by 53.0% in patients with mild to moderate hypophosphatemia using a two-pronged EHR intervention across a large safety-net setting.
住院患者血清磷酸盐的补充很常见,但补充实践存在很大的差异,导致过度使用。电子病历(EHR)干预措施结合临床决策支持(CDS)可以是指导临床医生最佳临床实践的有效工具。作者的目的是使用 CDS 工具减少大型保障医疗系统中低磷血症校正的过度使用。
第一项干预措施是通过纳入 CDS 来增强现有的磷酸盐补充医嘱集,根据缺陷严重程度指导适当的补充医嘱,并简化医嘱。第二项干预措施是当为轻度至中度磷酸盐缺乏症的患者开具静脉(IV)磷酸盐补充医嘱,而没有现有的禁食(NPO)医嘱时,触发最佳实践咨询(BPA)。主要结局指标是每 1000 个患者日,轻度和中度低磷血症患者接受 IV 替代治疗而无 NPO 医嘱的患者人数。
在所有医院中,没有 NPO 医嘱的轻度至中度低磷血症(1.0 至 1.9mg/dL)患者接受 IV 替代治疗的比例从每 1000 个患者日 7.22 例降至 3.40 例(53.0%减少,p<0.001),而该人群中口服替代治疗的比例从每 1000 个患者日 6.39 例增加至 8.87 例(38.8%增加,p<0.001)。对于磷酸盐水平≥2.0 的患者,IV 替代治疗从每 1000 个患者日 10.66 例减少至 5.36 例(49.8%减少,p<0.001),口服替代治疗从每 1000 个患者日 19.78 例减少至 16.69 例(15.6%减少,p<0.01)。
这项干预措施在大型保障医疗环境中,通过两项 EHR 干预措施,成功将轻度至中度低磷血症患者的住院 IV 磷酸盐替代治疗减少了 53.0%。